FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I): , wherein the residues R1, R1' and R1ʺ independently represent hydrogen, alkoxy, halogen or -CF3 group. The residue R2 it represents C1-7alkyl or phenyl, or a pharmaceutically acceptable salt thereof. Also pharmaceutical composition, using the compounds of formula I, and method of treatment are provided.
EFFECT: compounds of formula I are inhibitors immunoproteasomal subunit LMP7, and may be useful in the treatment of inflammatory diseases and disorders such as rheumatoid arthritis, lupus and irritable bowel syndrome.
13 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2637938C2 |
AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
NOVEL PYRROLIDINE DERIVATIVES | 2017 |
|
RU2736498C1 |
MONOCYCLIC L-NUCLEOSIDES, THEIR ANALOGUES AND USING | 1997 |
|
RU2188828C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
COMPOUND WITH A CYCLIC STRUCTURE | 2018 |
|
RU2795119C2 |
PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
QUINAZOLINE DERIVATIVES | 2005 |
|
RU2414468C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
SPIRO AMINO COMPOUNDS APPLICABLE FOR TREATING SLEEP DISORDERS AND DRUG ADDICTION | 2010 |
|
RU2562609C2 |
Authors
Dates
2017-07-19—Published
2013-11-29—Filed